Human Desmocollin-3 Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF4630
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Arg136-Lys690
Accession # Q14574
Specificity
Clonality
Host
Isotype
Applications for Human Desmocollin-3 Biotinylated Antibody
Western Blot
Sample: Recombinant Human Desmocollin-3 (Catalog # 4630-DC)
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Desmocollin-3
Desmocollin-3 is a 100‑110 kDa type I transmembrane glycoprotein that belongs to the cadherin family of calcium dependent adhesion molecules (1‑3). The human Desmocollin-3 is synthesized with a 108 amino acid (aa) propeptide. The mature protein consists of a 555 aa extracellular domain (ECD) that contains five cadherin‑like domains, a 21 aa transmembrane segment, and a 185 aa cytoplasmic domain (4, 5). Within the ECD, human Desmocollin-3 shares 78% aa sequence identity with mouse and rat Desmocollin-3. It shares 52% and 64% aa sequence identity with Desmocollin-1 and -2, respectively. A splice variant of human Desmocollin-3 has a truncated and substituted cytoplasmic domain (4, 6). Desmocollin-3 is one of the principal components of desmosomes which form adhesive contacts between epithelial cells (1, 2). It is expressed in the basal and suprabasal layers of stratified epithelia in many tissues (5, 7, 8). Desmocollin-1 and -2, by contrast, are preferentially localized in the more superficial layers (7). In mouse, Desmocollin-3 is expressed throughout embryogenesis and is required for non‑desmosomal functions during early development (9, 10). During apoptosis, both isoforms of Desmocollin-3 are proteolytically cleaved by caspases and metalloproteases (11). Desmocollin-3 can be up‑regulated or down‑regulated in carcinoma (6, 12, 13).
References
- Kottke, M.D. et al. (2006) J. Cell Sci. 119:797.
- Garrod, D.R. et al. (2002) Mol. Memb. Biol. 19:81.
- Leckband, D. and A. Prakasam (2006) Annu. Rev. Biomed. Eng. 8:259.
- Kawamura, K. et al. (1994) J. Biol. Chem. 269:26295.
- King, I.A. et al. (1995) J. Invest. Dermatol. 105:314.
- Klus, G.T. et al. (2001) Int. J. Oncol. 19:169.
- North, A.J. et al. (1996) Proc. Natl. Acad. Sci. 93:7701.
- Nuber, U.A. et al. (1996) Eur. J. Cell Biol. 71:1.
- Chidgey, M.A.J. et al. (1997) Dev. Dyn. 210:315.
- Den, Z. et al. (2006) J. Cell Sci. 119:482.
- Weiske, J. et al. (2001) J. Biol. Chem. 276:41175.
- Wang, L. et al. (2007) Virchows Arch. Sept. 11 epub.
- Boelens, M.C. et al. (2007) J. Clin. Pathol. 60:608.
Alternate Names
Gene Symbol
UniProt
Additional Desmocollin-3 Products
Product Documents for Human Desmocollin-3 Biotinylated Antibody
Product Specific Notices for Human Desmocollin-3 Biotinylated Antibody
For research use only